Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CLEOCIN® Phosphate Injection Principal Display Panel (clindamycin)

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL Vial Label

2 mL Vial
NDC 0009-0870-21

Cleocin
Phosphate®

clindamycin injection, USP
300 mg/2 mL*
(150 mg/mL)

For intramuscular or intravenous use

Rx only

Principal Display Panel - 300 mg/2 mL Vial Label

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL Vial Carton

NDC 0009-0870-26
Contains 25 of NDC 0009-0870-21

25—2 mL Single Dose Vials

Cleocin Phosphate®
clindamycin injection, USP

300 mg/2 mL*

(150 mg/mL)

For intramuscular or intravenous use

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Label

4 mL Vial
NDC 0009-0775-20

Cleocin Phosphate®
clindamycin injection, USP
600 mg/4 mL*
(150 mg/mL)

For intramuscular or intravenous use

Rx only

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Carton

NDC 0009-0775-26
Contains 25 of NDC 0009-0775-20

25—4 mL Single Dose Vials

Cleocin Phosphate®
clindamycin injection, USP

600 mg/4 mL*

(150 mg/mL)

For intramuscular or intravenous use

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL Vial Label

6 mL Vial
NDC 0009-0902-11

Cleocin Phosphate®
clindamycin injection, USP
900 mg/6 mL*
(150 mg/mL)

For intramuscular or intravenous use

Rx only

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL Vial Label

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL Vial Carton

NDC 0009-0902-18
Contains 25 of NDC 0009-0902-11

25—6 mL Single Dose Vials

Cleocin Phosphate®
clindamycin injection, USP

900 mg/6 mL*

(150 mg/mL)

For intramuscular or intravenous use

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 9,000 mg/60 mL Vial Bulk Label

NDC 0009-0728-05

60 mL Pharmacy
Bulk Package

Cleocin
Phosphate
®
clindamycin injection, USP
9,000 mg/60 mL*
(150 mg/mL)

For intramuscular or intravenous use
Not for direct infusion

Pfizer Injectables

Rx only

Distributed by Pharmacia & Upjohn Co
Division of Pfizer Inc, NY, NY 10017

PRINCIPAL DISPLAY PANEL - 9,000 mg/60 mL Vial Bulk Label

PRINCIPAL DISPLAY PANEL - 9,000 mg/60 mL Vial Bulk Carton

NDC 0009-0728-09
Contains 5 of NDC 0009-0728-05

5—60 mL Pharmacy Bulk Packages

Cleocin Phosphate®
clindamycin injection, USP

9,000 mg/60 mL*

(150 mg/mL)

For intramuscular or intravenous use
Not for direct infusion

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 9,000 mg/60 mL Vial Bulk Carton

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Label

NDC 0009-3124-01

Single Dose
4 mL ADD-Vantage™ Vial

Cleocin Phosphate®
clindamycin injection, USP
600 mg/4 mL*
(150 mg/mL)

For intravenous use only

Use only with the ADD-Vantage diluent container.

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL ADD-Vantage Vial Carton

25—4 mL Single Dose
ADD-Vantage® Vials

NDC 0009-3124-03
Contains 25 of NDC 0009-3124-01

Cleocin Phosphate®
clindamycin injection, USP

600 mg/4 mL*

(150 mg/mL)

For intravenous use only

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 600 mg/4 mL ADD-Vantage Vial Carton

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL Vial Label

NDC 0009-3447-01

Single Dose
6 mL ADD-Vantage™ Vial

Cleocin Phosphate®
clindamycin injection, USP
900 mg/6 mL*
(150 mg/mL)

For intravenous use only

Use only with the ADD-Vantage diluent container.

Pfizer Injectables

Rx only

Principal Display Panel - 900 mg/6 mL Vial Label

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL ADD-Vantage Vial Carton

25—6 mL Single Dose
ADD-Vantage® Vials

NDC 0009-3447-03
Contains 25 of NDC 0009-3447-01

Cleocin Phosphate®
clindamycin injection, USP

900 mg/6 mL*

(150 mg/mL)

For intravenous use only

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 900 mg/6 mL ADD-Vantage Vial Carton

PRINCIPAL DISPLAY PANEL - 300 mg/ 50 mL Container Label

NDC 0009-3381-01

Cleocin Phosphate® IV Solution
clindamycin injection

300 mg/ 50 mL*
in 5% DEXTROSE
Rx only

For Intravenous Use

Code 2G3414
Sterile, Nonpyrogenic

GALAXY Single Dose Container

Recommended storage: Room temperature (25°C). Avoid temperatures above 30°C.
DOSAGE AND USE:
See accompanying prescribing information.
Not for rapid injection or IV push.
Cautions: Do not add supplementary medication. Must not be used in series
connections. Check for minute leaks and solution clarity.
* Each 50 mL contains clindamycin phosphate equivalent to 300 mg clindamycin
and 2.5 g dextrose hydrous, USP with 2 mg edetate disodium dihydrate,
USP added. pH adjusted with sodium hydroxide and/or hydrochloric acid.
CLEOCIN PHOSPHATE is a registered trademark of
Pharmacia & Upjohn Company.
GALAXY is a registered trademark of Baxter International Inc.
Manufactured for Pfizer Inc by Baxter Healthcare
Corporation, Deerfield, IL 60015

Pfizer Injectables

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc
New York, NY 10017

PL 2501 Plastic
11152901
07-34-72-423

PRINCIPAL DISPLAY PANEL - 300 mg/ 50 mL Container Label

PRINCIPAL DISPLAY PANEL - 300 mg/ 50 mL Container Carton

2 x 12 x 50 mL Single Dose Containers
Contains 2 boxes of 12 of NDC 0009-3381-01

Cleocin Phosphate® IV Solution
clindamycin injection

Pfizer Injectables

300 mg/ 50 mL*
in 5% Dextrose
Rx only

NDC 0009-3381-02
Contains 24 of NDC 0009-3381-01
Code 2G3414

PRINCIPAL DISPLAY PANEL - 300 mg/ 50 mL Container Carton

PRINCIPAL DISPLAY PANEL - 600 mg/ 50 mL Container Label

NDC 0009-3375-01

Cleocin Phosphate® IV Solution
clindamycin injection

600 mg/ 50 mL*
in 5% DEXTROSE
Rx only

For Intravenous Use

Code 2G3415
Sterile, Nonpyrogenic

GALAXY Single Dose Container

Recommended storage: Room temperature (25°C). Avoid temperatures above 30°C.
DOSAGE AND USE:
See accompanying prescribing information.
Not for rapid injection or IV push.
Cautions: Do not add supplementary medication. Must not be used in series
connections. Check for minute leaks and solution clarity.
* Each 50 mL contains clindamycin phosphate equivalent to 600 mg clindamycin
and 2.5 g dextrose hydrous, USP with 2 mg edetate disodium dihydrate,
USP added. pH adjusted with sodium hydroxide and/or hydrochloric acid.
CLEOCIN PHOSPHATE is a registered trademark of
Pharmacia & Upjohn Company.
GALAXY is a registered trademark of Baxter International Inc.
Manufactured for Pfizer Inc by Baxter Healthcare Corporation,
Deerfield, IL 60015

Pfizer Injectables

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc
New York, NY 10017

PL 2501 Plastic
11153201
07-34-72-424

PRINCIPAL DISPLAY PANEL - 600 mg/ 50 mL Container Label

PRINCIPAL DISPLAY PANEL - 600 mg/ 50 mL Container Carton

2 x 12 x 50 mL Single Dose Containers
Contains 2 boxes of 12 of NDC 0009-3375-01

Cleocin Phosphate® IV Solution
clindamycin injection

Pfizer Injectables

600 mg/ 50 mL*
in 5% Dextrose
Rx only

NDC 0009-3375-02
Contains 24 of NDC 0009-3375-01
Code 2G3415

PRINCIPAL DISPLAY PANEL - 600 mg/ 50 mL Container Carton

PRINCIPAL DISPLAY PANEL - 900 mg/ 50 mL Container Label

NDC 0009-3382-01

Cleocin Phosphate® IV Solution
clindamycin injection

900 mg/ 50 mL*
in 5% DEXTROSE
Rx only

For Intravenous Use

Code 2G3416
Sterile, Nonpyrogenic

GALAXY Single Dose Container

Recommended storage: Room temperature (25°C). Avoid temperatures above 30°C.
DOSAGE AND USE:
See accompanying prescribing information.
Not for rapid injection or IV push.
Cautions: Do not add supplementary medication. Must not be used in series
connections. Check for minute leaks and solution clarity.
* Each 50 mL contains clindamycin phosphate equivalent to 900 mg clindamycin
and 2.5 g dextrose hydrous, USP with 2 mg edetate disodium dihydrate,
USP added. pH adjusted with sodium hydroxide and/or hydrochloric acid.
CLEOCIN PHOSPHATE is a registered trademark of
Pharmacia & Upjohn Company.
GALAXY is a registered trademark of Baxter International Inc.
Manufactured for Pfizer Inc by Baxter Healthcare Corporation,
Deerfield, IL 60015

Pfizer Injectables

Distributed by
Pharmacia & Upjohn Co
Division of Pfizer Inc
New York, NY 10017

PL 2501 Plastic
11153501
07-34-72-425

PRINCIPAL DISPLAY PANEL - 900 mg/ 50 mL Container Label

PRINCIPAL DISPLAY PANEL - 900 mg/ 50 mL Container Carton

2 x 12 x 50 mL Single Dose Containers
Contains 2 boxes of 12 of NDC 0009-3382-01

Cleocin Phosphate® IV Solution
clindamycin injection

Pfizer Injectables

900 mg/ 50 mL*
in 5% Dextrose
Rx only

NDC 0009-3382-02
Contains 24 of NDC 0009-3382-01
Code 2G3416

PRINCIPAL DISPLAY PANEL - 900 mg/ 50 mL Container Carton

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL ADD-vantage Vial Label

NDC 0009-6582-02

Single Dose
2 mL ADD-Vantage® Vial

Cleocin Phosphate®
clindamycin injection, USP
300 mg/2 mL*
(150 mg/mL)

For intravenous use only

Use only with the ADD-Vantage diluent container.

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL ADD-vantage Vial Label

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL ADD-Vantage Vial Carton

25—2 mL Single Dose
ADD-Vantage® Vials

NDC 0009-6582-01
Contains 25 of NDC 0009-6582-02

Cleocin Phosphate®
clindamycin injection, USP

300 mg/2 mL*

(150 mg/mL)

For intravenous use only

Pfizer Injectables

Rx only

PRINCIPAL DISPLAY PANEL - 300 mg/2 mL ADD-Vantage Vial Carton
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event